Upload
lamthien
View
217
Download
0
Embed Size (px)
Citation preview
NHS Digital Reform:Enabling Clinical Trials?
Presented by Jason Wakelin-SmithSenior GCP & GLP Inspector, MHRA
2
NHS IT – Back on the Agenda
Common message:“The ability to collect, aggregate and analyse the data generated by the NHS is not only critical to delivering the triple aims of healthcare, but also underpins the NHS and wider life sciences research strategies”
3
Moving with the Times?
eSystems
eTMF
eRX
eHR
eSource
eCRF
ePRO
• Organisation’s own systems
• Sponsor provided systems
• Equipment and associated software
• Supporting systems
*
4
Bring Your Own Device / Wearables
• Data collection / compliance assessment
• Metadata supporting primary data
• Data protection concerns?• Source data? • Investigator – control of
data?• Archiving and retention?
5
Primary Objective
To ensure that whichever solutions are chosen by each organisation include the capabilities to support the conduct of clinical trials in terms of:• Operational requirements• Regulatory requirements• Data integrity expectations• Realistic processes
6
Worst Case Scenario?
That data generated using the electronic systems could not be used to support clinical trials
That the electronic systems had not been designed to meet the requirements of clinical research and work-arounds are required
7
“If it’s not good enough for clinical trials…”
• Joint MHRA / DH Position statement on EHR (Sep 15)
• Sent to Trust CEOs• DH considered that if the
EHR was not fit for purpose for clinical trials then it would not be fit for purpose for routine clinical care
8
An electronic parallel? eTMF
Similar idea to that of the eHR– an electronic repository of trial data & documents
• Critical findings• Return visits• Significant amount of
work to resolve issues
“Where provision of the Trial Master File (TMF) does not
comply with Regulation 31A 1-3, as the TMF is not readily
available or accessible, or the TMF is incomplete to such an extent that it cannot form the
basis of inspection and therefore impedes or obstructs
inspectors carrying out their duties in verifying compliance
with the Regulations”
9
R&D Involvement?
• User requirements specification?• User acceptance testing?• Ways of working• Tailored requirements specific for CTIMPs?• Regulatory requirements and expectations• Risks?
10
Considerations: Standard Requirements
• Physical security• Restricted access• Managed permissions• Data protection• Back-up & recovery
Consider from CTIMP point of view!
11
Considerations: CTIMPs
• System to include CTIMPs• Audit trails to exist, be useful &
user-friendly• Amendments & additions to entries
to be obvious and require appropriate sign-off
• Investigator oversight / review of entries and data (e.g. labs, imaging)?
• Blinding• Archiving & retention
12
Process Design
ALCOA
Proportionate risk-based controls Ease of data
recording
Enables event reconstruction
Source data review
Principles equally applicable to paper and electronic systems
AttributableLegibleContemporaneousOriginalAccurate
13
Considerations: Live System
• Trust oversight of CTIMP requirements and processes inc.data integrity
• Processes & procedures
• Training
14
Multiple Systems• How do they fit together?• Touch points?• Dependencies & data
transfers• Access• Can you answer – “what
constitutes the patient’s medical record and where can the components be found”?
• System maps
15
Considerations: External Requirements
• External access:• Monitoring / audit• Inspection
• Exports of data?• Blinding & QC of
exports
“The printouts present in the investigator files for trial subjects were not always an accurate reflection of the
database content and the audit trails are not systematically printed and made available”
16
Patient Confidentiality
• Trial specific access• Read-only access• Appropriate
permission set• Access to audit trails• Across systems /
links?
17
Patient Confidentiality
• Trial specific access• Read-only access• Appropriate
permission set• Access to audit trails• Across systems /
links?
Current Work-around:• CRA provided with a
site access to EHR• Agreement to only view
trial patients• Site review of patient
records accessed• Company disciplinary
process• à Trust based
18
Audit trail example02 July 2014 ‘Inclusion criteria = COPD diagnosed > 3 months ago. FEV1 48% (PRE-bronchodilator).mMRC score >1. No exacerbations in last 12/12’
Visit 110 July 2014 ‘‘Inclusion criteria = COPD diagnosed > 3 months ago. FEV1 48% (PRE-bronchodilator).mMRC score >1. No exacerbations in last 12/12. Current COPD Rx = nil’
Post monitoring visit when eligibility queried03 October 2014 ‘Inclusion criteria = COPD diagnosed > 3 months ago. FEV1 48% (PRE-bronchodilator).mMRC score >1. No exacerbations in last 12/12. Current COPD Rx = Ventolin PRN’
19
Example: Scanning• Queries & concerns raised
about Trusts who were digitising medical records and then destroying the originals
• MHRA/DH Expectations: • Creation of certified copies• Mapping of content• Audit trails of creation,
amendment and deletion• Continuing access
• Advise original records retained. Could destroy originals (but at risk)
20
Scanning Issues
• Lack of robust QC process
• Scan order / missing sections
• Scan resolution / image capture
• Metadata / colour• Outsourcing & oversight• Search (image vs OCR)
21
Data Integrity
The extent to which all data are complete, consistent and accurate throughout the data lifecycle*
* from initial data generation and recording, through processing (including transformation or migration), use, retention, archiving and retrieval.
23
Summary
• The digital age is here and is to be embraced• We already work within a semi-digital CT world• Imperative that research/CTIMPs are considered early
in the design and procurement phase• You cannot ignore CT requirements• You will need to provide the necessary inputs and be
able to influence the direction of travel• You need to understand and be able to explain the
systems in use• Its not just about obtaining and commissioning the
system – it will need oversight and maintenance• Increased focus on data integrity
24
ReferencesICH E6 (R2)http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002874.pdf
E-Source Reflection Paperhttp://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2010/08/WC500095754.pdf
MHRA Electronic Health Records Position Statementfile:///H:/Electronic%20Health%20Records_MHRA%20Position%20Statement_Final%20(1).pdf
MHRA Data Integrity Guidance Documenthttps://www.gov.uk/government/news/mhra-gxp-data-integrity-definitions-and-guidance-for-industry
MHRA Inspectorate Blog https://mhrainspectorate.blog.gov.uk/https://mhrainspectorate.blog.gov.uk/2017/04/20/computer-system-validation-gcp/
26
© Crown copyright 2017About copyrightAll material created by the MHRA, including materials featured within these MHRA presentation notes and delegate pack, is subject to Crown copyright protection. We control the copyright to ourwork (which includes all information, database rights, logos and visual images), under a delegationof authority from the Controller of Her Majesty’s Stationery Office (HMSO).
The MHRA authorises you to make one free copy, by downloading to printer or to electronic, magnetic or optical storage media, of these presentations for the purposes of private research, study and reference. Any other copy or use of Crown copyright materials featured on this site, in any form or medium is subject to the prior approval of the MHRA.
Further information, including an application form for requests to reproduce our material can be found at www.mhra.gov.uk/crowncopyright
Material from other organisationsThe permission to reproduce Crown copyright protected material does not extend to any material in this pack which is subject to a separate licence or is the copyright of a third party. Authorisation to reproduce such material must be obtained from the copyright holders concerned.